类风湿性关节炎
医学
免疫学
关节炎
白细胞介素17
T细胞
细胞因子
白细胞介素2受体
标识
DOI:10.1007/978-1-4419-9371-7_22
摘要
The field of IL-17 biology has vastly increased recently. In 2005–2006, the cell source of IL-17 named TH17 cells was identified in mice and then in humans. The IL-17 protein had been discovered 10 years earlier as a T cell derived cytokine. These new findings on TH17 cells have led to an update of the classification of T cells into effector T cell subsets. The discovery of IL-17 was immediately linked to rheumatoid arthritis (RA). The first indication that T cells producing IL-17 could be a different subset was also first shown using T cell clones from RA synovial fluid and synovium. These findings have led to the concept of IL-17 targeting for treatment of various inflammatory conditions, including RA. We will review these findings focusing on human RA as the prototypic chronic inflammatory disease where inflammation leads to matrix destruction. However, some of these observations also apply to other diseases and such concepts are leading to new therapeutic applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI